Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- CloBu4Independent statistical analysis of Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS: Complete Statistical AnalysisIndependent statistical analysis of Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx): Complete Statistical AnalysisIndependent statistical analysis of Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin’s Lymphoma That Has Relapsed or Not Responded to Previous Treatment: Complete Statistical AnalysisIndependent statistical analysis of Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment: primary endpoint results, effect estimate with confidence interval,…
- Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size…
- Clonidine Versus Adenosine to Treat Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of Clonidine Versus Adenosine to Treat Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00349921).
- CLOR-PROIndependent statistical analysis of Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03760718).
- Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia: Complete Statistical AnalysisIndependent statistical analysis of Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255629).
- Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis: Complete Statistical AnalysisIndependent statistical analysis of Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02180828).
- Cluster-randomized Controlled Trial of Mindfulness-Based Cognitive Therapy Effects on Anxiety and Stress: Complete Statistical AnalysisIndependent statistical analysis of Cluster-randomized Controlled Trial of Mindfulness-Based Cognitive Therapy Effects on Anxiety and Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CM Asia Nail With AS2 Without AS2 （AS2 Study）: Complete Statistical AnalysisIndependent statistical analysis of CM Asia Nail With AS2 Without AS2 （AS2 Study）: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03196193).
- CM HIV-CORE008Independent statistical analysis of Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CM-101 in PSC Patients -The SPRING Study: Complete Statistical AnalysisIndependent statistical analysis of CM-101 in PSC Patients -The SPRING Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04595825).
- CMHIndependent statistical analysis of Cirrhosis Medical Home: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04581369).
- CMICEIndependent statistical analysis of A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01558362).
- CMRIndependent statistical analysis of Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CMT2014/2Independent statistical analysis of Carbetocin Myocardium Trial 2014 Part 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03899961).
- CNPIndependent statistical analysis of Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®: Complete Statistical AnalysisIndependent statistical analysis of Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01694771).
- Co-SOFTIndependent statistical analysis of Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02: primary endpoint results, effect estimate with…
- CO2 Versus Air Insufflation for Single-balloon Enteroscopy: Complete Statistical AnalysisIndependent statistical analysis of CO2 Versus Air Insufflation for Single-balloon Enteroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01758900).
- CO2 Versus Lund De-airing Technique in Heart Surgery: Complete Statistical AnalysisIndependent statistical analysis of CO2 Versus Lund De-airing Technique in Heart Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00934596).
- Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt: Complete Statistical AnalysisIndependent statistical analysis of Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt: primary endpoint results, effect estimate with confidence interval, sample-size…
- COASTIndependent statistical analysis of OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04757636).
- COASTIndependent statistical analysis of Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy: primary endpoint results, effect estimate with confidence…
- COBALTIndependent statistical analysis of Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- COBALTIndependent statistical analysis of A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- COBALTIndependent statistical analysis of Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury: Complete Statistical AnalysisIndependent statistical analysis of Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00597818).
- CoBIS 2Independent statistical analysis of Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COBRITIndependent statistical analysis of Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- COBRRAIndependent statistical analysis of Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- COCAIndependent statistical analysis of Neurocircuit Strategy to Decrease Cocaine Cue Reactivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04155632).
- Cochlear Implantation for Treatment of Single-sided Deafness: Complete Statistical AnalysisIndependent statistical analysis of Cochlear Implantation for Treatment of Single-sided Deafness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532972).
- COCOA-PADIndependent statistical analysis of Cocoa to Improve Walking Performance in Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02876887).
- COCOVIndependent statistical analysis of Care Outcomes for Chiropractic Outpatient Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03254719).
- CODAIndependent statistical analysis of The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Code SepsisIndependent statistical analysis of Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CODEXIndependent statistical analysis of Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD: primary endpoint results, effect estimate with confidence interval, sample-size…
- CODIACSQoLIndependent statistical analysis of Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CoFAR7Independent statistical analysis of Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CognitionIndependent statistical analysis of Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01333501).
- Cognitive Behavior Therapy and Work Outcome: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavior Therapy and Work Outcome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00810355).
- Cognitive Behavior Therapy for Work Success in Veterans With Mental Illness: A Pre-post Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavior Therapy for Work Success in Veterans With Mental Illness: A Pre-post Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…